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In the hematopoietic system, Notch signaling spec-
ifies T cell lineage fate, in part through negative reg-
ulation of B cell and myeloid lineage development.
However, we unexpectedly observed the develop-
ment of megakaryocytes when using heterotypic
cocultures of hematopoietic stem cells with OP9
cells expressing Delta-like1, but not with parental
OP9 cells. This effect was abrogated by inhibition
of Notch signaling either with g-secretase inhibitors
or by expression of the dominant-negative Master-
mind-like1. The importance of Notch signaling for
megakaryopoietic development in vivo was con-
firmed by using mutant alleles that either activate
or inhibit Notch signaling. These findings indicate
that Notch is a positive regulator of megakaryopoie-
sis and plays a more complex role in cell-fate deci-
sions among myeloid progenitors than previously
appreciated.
INTRODUCTION
The Notch signaling pathway is highly conserved among multi-
cellular organisms and has been implicated in a broad range of
developmental processes through biological mechanisms that
include proliferation, apoptosis, border formation, and cell-fate
decisions (Bray, 2006; Wilson and Radtke, 2006). In mammals,
there are four single-pass transmembrane Notch receptors
(Notch1–4) and five transmembrane ligands (Delta-like [DL]-1/
3/4, Jagged-1/2). Most Notch receptor functions are attributable
to a canonical signaling pathway that is initiated when the extra-
cellular portion of a Notch receptor binds one of its cognate
ligands. This interaction promotes two successive proteolytic
cleavages in Notch that are catalyzed first by ADAM family met-
alloproteases and then by g-secretase (Schroeter et al., 1998).314 Cell Stem Cell 3, 314–326, September 11, 2008 ª2008 ElsevierThe latter cleavage releases the intracellular domain of Notch
(ICN) from the membrane, allowing it to translocate to the
nucleus. In the nucleus, ICN binds to RBPJ (also known as
CSL), enabling recruitment of Mastermind-like (MAML) and other
critical coactivators, such as p300 or PCAF, that are required for
transcriptional activation. The few known direct Notch signaling
transcriptional targets include members of the basic helix-loop-
helix Hairy enhancer of split (Hes) factors, Hes-related repressor
proteins (Herp), Nrarp, Deltex, pre-T cell receptor a, and Gata-3
(Amsen et al., 2007; Fang et al., 2007; Wilson and Radtke, 2006).
In the hematopoietic system, the best-characterized role
of Notch signaling is the specific and nonredundant function of
Notch1 in T cell over B cell specification and development of
T cell progenitors toward the ab-T cell lineage (Radtke et al.,
2004b). Although Notch1-dependent events can be initiated by
both DL1 and DL4 in vitro, recent studies suggest that DL4
may be the physiological ligand of Notch1 in vivo (Besseyrias
et al., 2007). Conditional inactivation studies have shown that
developing thymocytes are dependent on Notch1 until comple-
tion of VDJ-b rearrangements at the double-negative (DN)-3
stage. Further maturation of the developing T cells to the DN4
and CD4+CD8+ double-positive (DP) stages requires attenuation
of Notch signaling and coincides with the downregulation of
Notch1 (Hasserjian et al., 1996; Huang et al., 2003). Enforced ex-
pression of Notch1 at this transitional stage interferes with pos-
itive selection and development of CD4 or CD8 single-positive
T cells (Visan et al., 2006). The importance of stage-specific
regulation of Notch activation during T cell development is
underscored by Notch mutations associated with malignant
transformation of the T cell lineage (Weng et al., 2004). More
than 50% of patients with T cell acute lymphoblastic leukemia
bear activating Notch1 receptor mutations localized within the
heterodimerization domain and/or the PEST domain, which
regulates protein stability of the receptor. Apart from its well-
established role in lymphopoiesis, the role of Notch signaling on
other aspects of hematopoiesis, including hematopoietic stem
cell (HSC) self-renewal and myeloid differentiation, has been con-
troversial (de Pooter et al., 2006; Mancini et al., 2005; Stier et al.,Inc.
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generally supports the notion that Notch not only negatively
regulates B cell lineage but also myeloid lineage development
as a concomitant of its role in supporting T cell-fate decisions.
Megakaryopoiesis is the mechanism by which HSCs differen-
tiate into mature megakaryocytes that ultimately produce plate-
lets, critical for hemostasis in the peripheral blood vasculature.
The megakaryocytic lineage is thought to derive directly from
a common bipotent megakaryocyte-erythrocyte progenitor
(MEP) (Akashi et al., 2000; Debili et al., 1996). However, it
remains controversial whether MEPs arise from a committed
common myeloid progenitor (CMP) (Akashi et al., 2000), directly
from a very primitive uncommitted HSC (Adolfsson et al., 2005;
Forsberg et al., 2006), or from both developmental pathways.
The thrombopoietin receptor (MPL) and its ligand, thrombopoie-
tin (TPO), are essential for the proliferation of megakaryocyte
progenitors and their differentiation into mature platelet-
producing megakaryocytes (Goldfarb, 2007; Kaushansky,
2005). However, although megakaryocyte numbers are mark-
edly reduced in MPL-deficient mice, these animals still produce
both megakaryocytes and platelets, indicating that HSCs are
capable of fate decisions that result in megakaryopoiesis in
the absence of MPL. Several transcription factors, including
GATA-1, GATA-2, FOG1/ZFPM1, RUNX1, and NFE2, are impor-
tant for normal megakaryopoiesis, but among the hematopoietic
transcription factors expressed by erythroid and megakaryo-
cytic lineages, no single factor has been identified that exclu-
sively specifies megakaryocytic fate (Goldfarb, 2007). Therefore,
a unifying mechanism controlling these different transcription
factors as they cooperate to engage megakaryocytic cell fate
remains to be elucidated. In this report, we demonstrate
a previously unappreciated role for Notch signaling as a positive
regulator of megakaryocyte fate.
RESULTS
The DL1/Notch Axis Induces Megakaryocyte
Differentiation of LSK In Vitro
Murine bone marrow LinSca-1+cKit+ (LSK) cells were cocul-
tured, in the absence of exogenous cytokines, on OP9-GFP cells
or OP9 cells expressing the Notch ligand Delta-like1 (OP9-DL1)
(Schmitt et al., 2004; Schmitt and Zuniga-Pflucker, 2002) (see
Figure S1 available online). Phase-contrast microscopy showed
that LSK cells cultured on OP9-DL1 cells, but not OP9-GFP,
gave rise to large cells with cytoplasmic protrusions reminiscent
of proplatelet production by megakaryocytes (Figure 1A). The
megakaryocytic nature of these cells was confirmed by Wright-
Giemsa and acetylcholinesterase (AchE) staining that demon-
strated large AchE+ cells with multilobated nuclei in OP9-DL1,
but not OP9-GFP cocultures (Figure 1A and Figure S2B). Flow
cytometric analyses showed that LSK cells cocultured with
OP9-DL1 gave rise to a transient population of CD41+Ter119+
DP cells after 5 days (Figure S2A) and to a population of
CD41+Ter119 (Figures 1B and 1C) cells by day 8 of coculture,
whereas few CD41Ter119+ or CD41Mac1+ cells were de-
tected. In contrast, LSK cells cocultured with OP9-GFP differen-
tiated into both CD41Ter119+ erythroid cells and CD41Mac1hi
granulocyte-macrophage cells (Figures 1B and 1C). Additional
evidence for enhanced megakaryopoiesis in LSK/OP9-DL1Cellcocultures compared to LSK/OP9-GFP cocultures included an
elevated number of CD41+CD42b+ megakaryocytes and an
increased median ploidy (Figures S2C and S2D) as well as an
increased capacity to form megakaryocyte colonies (CFU-Mk)
after replating in methylcellulose or collagen-based semisolid
cultures (Figures S3). We next tested the effect of coculturing hu-
man hematopoietic cells with OP9-DL1. As was observed for the
murine LSK cells, flow cytometric analysis of human bone mar-
row CD34+ cells cultured on OP9-DL1 stroma showed increased
numbers of CD41+ cells and decreased numbers of Mac1+ cells
compared to cells cultured on OP9-GFP (data not shown). To-
gether, these results indicate that in vitro stimulation of murine
LSK or human CD34+ cells with DL1 suppresses granulocyte-
macrophage and erythroid differentiation but promotes megakar-
yocytic maturation. The observation of a transient CD41+Ter119+
DP population (Figure S2A) further suggests that megakaryo-
cytes observed at day 8 of coculture may arise from a progenitor
with combined erythroid and megakaryocytic potential.
Canonical Notch Pathway Mediates
Megakaryocyte Fate
To confirm that Notch signaling was the basis for induction
of megakaryocyte development by OP9-DL1 stroma, we first
treated the cocultures with Compound E or DAPT, two g-secre-
tase inhibitors that prevent cleavage of the Notch receptors and
pathway activation (De Smedt et al., 2005; Weng et al., 2004).
The increase in megakaryocyte differentiation upon coculture
of LSK cells with OP9-DL1 cells was abrogated by addition of
either these inhibitors (Figure 1D and data not shown). These
findings indicate that pharmacologic agents selectively inhibiting
the Notch pathway abrogate megakaryocytic and restore
granulocyte-macrophage differentiation of LSK cells cultured
on OP9-DL1 cells.
We next tested the role of Notch-mediated transcriptional ac-
tivation in megakaryopoiesis. We utilized a dominant-negative
MAML1 mutant (dnMAML1), fused to GFP, that entraps all four
mammalian intracellular Notch (ICN1–4) in transcriptionally inert
RBPJ/ICN/dnMAML1 complexes (Nam et al., 2006; Weng et al.,
2003) and is therefore a potent inhibitor of Notch-mediated
transcription. LSK cells transduced with dnMAML1 prior to the
initiation of cocultures with OP9-DL1 failed to differentiate into
CD41+ cells (Figure 2A). Conversely, expression of ICN1 or
ICN4 in LSK cells cultured on OP9-GFP stroma was sufficient
to induce megakaryopoiesis in the absence of DL1 stimulation,
with a marked increase in CD41+ cells (Figure 2B). Retroviral
transduction and expression of the Notch targets, Hes1 or
Hes5, in LSK cells partially recapitulated megakaryocyte differ-
entiation on OP9-GFP stroma in the absence of DL1 stimulation
(Figure 2B). Importantly, ICN4 expression rescued the inhibition
of megakaryocyte development by g-secretase inhibitor on OP9-
DL1 stroma (Figure 2C). Taken together, these results indicate
that activation of the RBPJ/ICN/MAML complex in the LSK com-
partment mediates megakaryocytic fate determination in vitro.
Notch Signaling Initiates a Megakaryopoietic
Transcriptional Program
To gain insight into the molecular basis for the DL1-induced
megakaryopoiesis, we first assessed expression of the Notch
target Hes-1 (Jarriault et al., 1995) by quantitative RT-PCRStem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier Inc. 315
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(A) Flow-sorted LSK cells were plated on OP9-GFP or OP9-DL1 stroma. (Left panels) Phase-contrast microscopy of day 8 LSK cells/OP9-GFP or OP9-DL1
stroma cocultures. Arrowheads indicate megakaryocytes observed in OP9-DL1 cocultures. Original magnification is3400. (Middle and right panels) Acetylcho-
linestesterase (AchE) staining of cytospun cells from cocultures. Original magnification was 3100 and 3600, respectively. Brown coloring indicates positivity
for AchE.
(B) Flow cytometric analysis of CD45+ cells derived from day 8 LSK/OP9-GFP or OP9-DL1 cocultures.
(C) Histogram representation of flow cytometric results presented in (B). Mean ± SEM of five independent flow cytometric analyses after 8 days of coculture is
shown.
(D) g-secretase inhibition abrogates biological and molecular effects of DL1 stimulation. LSK cells cultured on OP9-DL1 stroma in the presence of DMSO (control)
or Compound E (CompE, 1 mM) were analyzed for megakaryocytic differentiation.analysis. LSK-derived cells obtained after 5 days of coculture
with OP9-DL1 showed a 50-fold increase in expression of Hes-1
compared to cells derived from OP9-GFP cocultures, an effect
that was also abrogated by addition of Compound E (Figure 3A).
Furthermore, expression of GATA-1 and Fli-1, two transcription
factors that are required for normal megakaryopoiesis (Deveaux
et al., 1996), was also increased in cells cultured on OP9-DL1
compared to OP9-GFP stroma. Conversely, expression of
PU.1, a transcription factor that is essential for normal myeloid
development and antagonizes GATA-1 (Nerlov et al., 2000;
Rekhtman et al., 1999; Zhang et al., 1999), showed decreased
expression in LSK cocultures with OP9-DL1 compared to
OP9-GFP stroma (Figure 3A).316 Cell Stem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier ITo have a comprehensive view of the transcriptional changes
associated with Notch-induced megakaryocyte development,
we performed global gene expression array analysis of LSK cells
cultured for 3 days on OP9-GFP, OP9-DL1, or OP9-DL1 supple-
mented with Compound E, respectively. We generated two lists
of genes implicated in the Notch signaling pathway or in mega-
karyopoiesis (Notch and Megakaryocyte Gene Lists, respec-
tively, Tables S1 and S2) and performed gene set enrichment
analysis (GSEA) (Krivtsov et al., 2006; Subramanian et al., 2005),
a computational method that determines whether a defined
gene set shows differential expression between two biological
states. When comparing LSK/OP9-GFP and LSK/OP9-DL1
coculture conditions, we observed a significant enrichment ofnc.
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Notch Specifies Megakaryocyte FateFigure 2. RBPJ/ICN/MAML Complex Mediates Megakaryocyte Development
(A and B) LSK cells were transduced with retroviruses encoding either dnMAML1, ICN1, ICN4, HES1, HES5, or MIG-empty vector control and subsequently
plated on OP9-GFP or OP9-DL1 stroma.
(C) LSK cells were transduced as in (A) and (B) and plated in presence of 1 mM Compound E or mock (DMSO) control. FACS analyses of CD45+GFP+ cells were
performed after 8 days of coculture.Notch target genes in the latter condition, consistent with activa-
tion of the Notch pathway by DL1 (Figures S4A and S4B). We
also observed significant enrichment in megakaryocyte-specific
genes when comparing the LSK/OP9-DL1 with LSK/OP9-GFP
coculture conditions (Figures 3B and 3C). The ‘‘leading edge’’
genes, the subset of the Megakaryocyte Gene List that accounts
for the enrichment, included those encoding transcription fac-
tors (e.g., GATA-1, GATA-2, FOG1/ZFPM1, NFE2), cytokine
receptors (e.g., MPL, IL1R, KIT, PDGFRb), and structural or
granule proteins (e.g., ITGA2B, ITGB3, GP1BA, CD9, VWF). In
contrast, the expression of the leading edge genes derived
from the Megakaryocyte Gene List was not increased when
Compound E was added to the LSK cells/OP9-DL1 cocultures
(Figures 3C and 3D). Taken together, these findings indicate
that DL1-stimulated LSK cells engage a transcriptional program
characteristic of both Notch pathway activation and megakaryo-
cyte development.
Notch Specifies Megakaryocyte Fate at Several
Levels of HSC Differentiation
To measure the frequency of LSK cells that can develop into
megakaryocytes, individual wells of 96-well plates coated with
either OP9-GFP or OP9-DL1 stroma were seeded with 1, 2, 5,Cell Sor 20 LSK cells. Assessment of megakaryocyte development
after 8 days of culture indicated that about 1 in 12 LSK cells
can give rise to megakaryocytes on OP9-DL1 stroma compared
to an estimated 1 in 360 on OP9-GFP stroma (Figure 4A). To
determine which subpopulation of LSK cells is the most efficient
for megakaryocyte development, we fractionated LSK cells
(Adolfsson et al., 2005; Forsberg et al., 2006; Pronk et al.,
2007), based on their expression of Flt3 and CD34, into
long-term HSC (Flt3CD34LSK cells), short-term HSCs
(Flt3CD34+LSK cells), and lymphoid-primed multipotent pro-
genitors (Flt3+CD34+LSK) and plated them in OP9-GFP and
OP9-DL1 cocultures (Figure 4B). Differentiation toward CD41+
cells was more important when LT- and ST-HSCs were plated
on OP9-DL1, compared to LMPP. Of note, LT- and ST-HSCs
also showed an increased differentiation toward erythroid and
megakaryocytic lineages when cultured with OP9-GFP stroma.
Together, these results suggest that Notch stimulation favors
megakaryocyte differentiation of LSK cells at the single-cell
level, and although all LSK subpopulations can differentiate
into megakaryocytes upon Notch stimulation, LT- and ST-HSC
appear more efficient at this process compared to LMPP.
To investigate the role of Notch on more committed myeloid
progenitors in vivo, we first analyzed quantitative expression oftem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier Inc. 317
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(A) RNA from LSK cells cocultured with OP9-GFP or OP9-DL1 in the presence or absence of Compound E (1 mM) for 5 days was used to perform analysis of Hes-1,
Gata-1, Fli-1, and PU.1 expression normalized to Gapdh. Mean ± SEM of duplicate experiments is represented.
(B) Flow-sorted LSK cells were cultured on stroma (OP9-GFP, OP9-DL1, or OP9-DL1 supplemented with 1 mM Compound E). After 3 days of cocultures, RNA
from nonadherent cells was extracted, amplified, labeled, and hybridized on mouse 430.2E Affymetrix chips. Expression data were analyzed for a list of genes
positively involved in megakaryopoiesis by using GSEA. Enrichment plot showing upregulation of megakaryocyte-specific genes in OP9-DL1 versus OP9-GFP
and OP9-DL1+Compound E. P value and FDR are indicated.
(C) Heat map representation of the expression of the top 50 megakaryocyte leading edge genes enriched in OP9-DL1 cultures compared to OP9 and OP9-DL1
supplemented with inhibitor cultures.
(D) Venn diagram representation of megakaryocytic genes induced by Notch pathway activation in LSK cells.Notch receptors on various myeloid progenitor populations
purified by flow cytometry (Figure 4C). Notch 1 and 2 were ex-
pressed on CMPs, megakaryocyte and erythroid progenitors
(MEPs), and granulocyte-macrophage progenitors (GMPs)
(Akashi et al., 2000). Of note, Notch1 showed the lowest expres-
sion in MEP, whereas Notch4 showed the highest expression in
MEP and was not detectable in GMP. Notch3 expression was
not detected in any cell population (data not shown). The Notch
targets Hes1 and Hey1 showed the highest expression in MEP,
intermediate expression in CMP, and minimal expression in
GMP, and Hes5 was only expressed in CMP and MEP
(Figure 4D). The correlation between expression of Notch recep-
tors and their transcriptional targets indicated that the Notch sig-318 Cell Stem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier Inaling pathway had been activated in CMP and MEP in vivo. In
order to assess the biological effect of Notch pathway stimula-
tion on these progenitors, CMP, MEP, and GMP were flow sorted
and plated on stroma. Both CMP and MEP plated on OP9-DL1
differentiated preferentially toward the megakaryocyte lineage
compared to those plated on OP9-GFP cocultures (Figures 4E
and 4F) and showed an increased CFU-Mk potential after replat-
ing in methylcellulose or collagen-based semisolid cultures
(Figure S3). GMP plated on OP9-DL1 showed a reduced differ-
entiation toward Mac1hi myeloid cells compared to OP9-GFP
cocultures and did not show any megakaryocyte development
(Figure S5A). Of note, GMP plated on OP9-DL1 for 24 hr showed
an increase in apoptosis compared to OP9-GFP cocultures,nc.
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(A) Limiting dilution assay with LSK cells from wild-type murine bone marrow directly sorted into individual OP9-GFP or OP9-DL1-coated 96-well plates with 1, 2,
5, or 20 cells per well and cultured for 8 days. Cocultures were analyzed under a microscope: wells with visible hematopoietic cells were scored and megakar-
yocytes were counted. Frequency of megakaryocyte-containing wells is represented, and trend lines were used to estimate the frequency of megakaryocyte-
forming cells in the LSK population.
(B) Flow-sorted LinSca1+Kit+CD34Flt3 (LT-HSC), LinSca1+Kit+CD34+Flt3 (ST-HSC), and LinSca1+Kit+CD34+Flt3+ (LMPP) cells were plated directly onto
OP9-GFP or OP9-DL1 stroma. Flow cytometric analysis was performed after 7 days of coculture.
(C and D) RNA from flow-sorted CMP, MEP, and GMP were extracted, amplified, and used for analysis of quantitative expression of Notch receptors (C) and the
Notch targets Hes-1, Hes-5, and Hey-1 (D). Results were normalized to GAPDH expression and to the MEP value. Notch3 expression was not detected in any
sample. Error bars represent SEM.
(E) Flow-sorted CMP were cultured on OP9-GFP or OP9-DL1 for 5 days before analysis by flow cytometry.
(F) Flow-sorted MEP were cultured on OP9-GFP or OP9-DL1 for 3 days before analysis by flow cytometry.whereas no significant difference in apoptosis was observed
with MEP (Figure S5B). At the level of MEP, DL1 stimulation re-
sulted in increased expression of several Notch targets including
Hes1, Hey1, and Nrarp as well as genes important for megakar-
yopoiesis including Gata1, Gata2, and Fli1 (Figure S4C). Of inter-
est, the Notch-induced megakaryocyte differentiation of CMP
and MEP was potentiated by addition of low concentrations of
TPO in OP9-DL1 cocultures (Figure S6). In addition, the TPO-
induced megakaryocyte differentiation observed on OP9-GFP
was significantly inhibited by g-secretase inhibitor treatment
(Figure S6), suggesting a potential crosstalk between the Notch
and TPO/MPL signaling pathways during megakaryocyte differ-
entiation. Together, these results suggest that the Notch signal-
ing pathway is activated in myeloid-committed CMP and MEP
in vivo and favors megakaryocytic fate through concomitantCellinduction of a megakaryocytic transcriptional program and
apoptosis in the GMP compartment.
Inhibition of Notch Signaling Impairs
Megakaryopoiesis In Vivo
We next assessed the effects of Notch signaling on megakaryo-
cyte development in vivo using bone marrow transplantation
assays with wild-type bone marrow cells transduced with
murine ecotropic retrovirus encoding dnMAML1 or empty vector
controls (MIG). Expression of dnMAML1 resulted in a reduction
in the number of MEP and megakaryocyte progenitors
(c-Kit+CD41+) (Figures 5A and 5B, respectively). In addition,
dnMAML1-expressing cells showed a significant reduction in
the number of maturing megakaryocyte as assessed by the
presence of CD41+, CD42b+, or CD41/CD61+ cells in the boneStem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier Inc. 319
Cell Stem Cell
Notch Specifies Megakaryocyte FateFigure 5. DnMAML1 Inhibits Megakaryocyte Development In Vivo
(A) Wild-type bone marrow cells were infected with dnMAML1-encoding or MIG control retroviruses and injected into lethally irradiated syngeneic recipients.
Analysis was performed after 3–6 weeks. Flow cytometric analysis of myeloid progenitors within the LineagecKit+Sca1 population. Analysis was gated on
GFP+ cells. A representative of five independent animals is shown for each group. Mean ± SEM for a total of five independent animals is represented below
as histograms.
(B) Analysis of the megakaryocyte progenitors c-Kit+CD41+ population (gated on Lineage GFP+cells) in the bone marrow of MIG versus dnMAML1 recipient
animals.
(C) FACS analyses of GFP+ dnMAML1 recipient bone marrow cells indicate impaired megakaryocyte development compared to MIG control recipients.
(D) Immunohistochemical (IHC) analysis of consecutives bone marrow sections shows reduced staining for the megakaryocyte-specific vWF and mostly GFP
megakaryocytes in dnMAML1 recipients, compared to MIG controls. For both vWF and GFP immunostainings, positive cells show a dark brown color. Black and
white arrowheads indicate GFP+ and GFP megakaryocytes, respectively. Original magnifications are 3100 (vWF) and 31000 (GFP).
(E) Fifty megakaryocytes were counted on bone marrow sections stained for GFP, and the percentages of GFP+ megakaryocytes are shown (white histograms).
The percentages of GFP+ total bone marrow (BM) cells were assessed in the same recipients by flow cytometry and are also shown (black histograms).
Histograms represent mean ± SEM of three independent animals for each group.
(F) Ploidy analysis was performed by flow cytometry using propidium iodide and gating on GFP+CD41+ megakaryocytes. Median ploidy is indicated above the
histogram (value for diploid state = 2).320 Cell Stem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier Inc.
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by histological analyses of bone marrow sections of these recip-
ients showing decreased numbers of mature von Willebrand
Factor (vWF)+ megakaryocytes in dnMAML1 recipients. Of
note, although GFP expression in total bone marrow cells was
high in dnMAML1 recipients (82% ± 13%), those mature mega-
karyocytes that were present in animals transduced with
dnMAML1 displayed low to absent GFP expression by immuno-
histochemistry (Figures 5D and 5E). This observation suggests
that megakaryocyte development only occurred in untrans-
Figure 6. DnMAML1 Conditional Knockin Mice Have Impaired
Megakaryopoiesis
(A) DnMAML1 cKI-Mx1Cre double transgenic animals were induced with
poly(I:C) at 6 weeks of age and analyzed 2–3 weeks later. A representative
flow cytometric analysis of myeloid progenitors within the LineagecKit+Sca1
population is shown. Mean ± SEM of three independent analyses gated on
GFP+ cells is shown below as histograms.
(B) Flow-sorted CMPs were plated in methylcellulose cultures supplemented
with IL3, IL6, SCF, EPO, and TPO, and colonies were counted after 7 days.
GM, granulocyte-macrophage colony; GEMM, granulocyte-macrophage-
erythroid-megakaryocyte colony; EMk, erythroid-megakaryocyte colony;
E, erythroid colony; Mk, megakaryocyte colony; cKI, conditional knockin.
Mean ± SEM (n = 3) are shown.Cellduced cells or in cells that expressed very low levels of
dnMAML1. Bone marrow cellularity and platelet counts were
comparable between dnMAML1 and MIG control transplanted
animals (Figure S8 and data not shown). DNA content analysis
of bone marrow-derived megakaryocytes showed a reduced
median ploidy of GFP+CD41+ megakaryocytes in dnMAML1
recipients compared to control animals (Figure 5F).
To exclude the possibility that dnMAML1-expressing hemato-
poietic progenitors fail to engraft properly, we analyzed a trans-
genic mouse harboring a dnMAML1-GFP fusion conditional
knockin allele (dnMAML1 cKI) (Maillard et al., 2008; Tu et al.,
2005). In this model, dnMAML1 expression is induced in adult
dnMAML1 cKI-Mx1Cre double transgenic mice by injection of
poly(I:C). Compared to LSK cells derived from Mx1Cre-only
control animals, LSK cells derived from conditional dnMAML1
cKI-Mx1Cre animals 2 to 3 weeks after pIpC injection did not
differentiate efficiently toward megakaryocytes when plated on
OP9-DL1 stroma (Figure S7B), similar to LSK cells transduced
with the dnMAML1-encoding retrovirus. In addition, dnMAML1-
induced animals showed a significant reduction in the numbers
of MEP, but not CMP or GMP compared to controls, specifically
in dnMAML1-expressing GFP+ cells (Figure 6A). As the MEP
population was barely detectable in dnMAML1 cKI animals,
functional validation of the megakaryocyte potential in dnMAML1-
expressing progenitors was obtained by assessing myeloid-
colony-forming potential of the CMP population. GFP+ CMP
from dnMAML1 animals displayed a significantly decreased po-
tential to form either megakaryocyte- or erythrocyte-containing
colonies, but not granulocyte-macrophage colonies, compared
to control CMP (Figure 6B). Of further interest, dnMAML1-ex-
pressing CMP showed reduced expression levels of several
Notch targets such as Hes1, Hes5, and Hey1 (Figure S7C). These
data together indicate that the development of MEPs and mega-
karyocyte progenitors, as well as subsequent megakaryocyte
maturation, is impaired in vivo by dnMAML1, a global inhibitor
of canonical Notch signaling.
ICN4 Expression Supports Megakaryopoiesis In Vivo
We next performed bone marrow transplants with cells trans-
duced with ICN4 to assess the effect of increased Notch signal-
ing on megakaryopoiesis in vivo. To preclude confounding re-
sults related to development of T cell leukemia in this model
system, we used Rag1/ bone marrow as a source of donor
cells (Pear et al., 1996; Stier et al., 2002). Flow cytometric
analysis showed a significant increase in the number of MEP in
ICN4-expressing GFP+ cells compared to MIG controls (Figures
7A and 7B). In contrast, the number of GMPs, as well as
c-Kit+CD71+ and c-KitCD71+ erythroid progenitors, was re-
duced in ICN4 recipients compared to control animals
(Figure 7A and Figure S9). Accordingly, bone marrow cells
from ICN4 animals gave rise to a higher number of CFU-MK
colonies compared to control recipients (Figure 7C). In addition,
immunohistochemistry of bone marrow sections for GFP and
vWF showed an increase in the absolute number of mature
megakaryocytes in ICN4 animals (Figure 7D). Most megakaryo-
cytes were GFP+, although GFP expression in total bone marrow
cells was low (Figure 7E), indicating selectivity for megakaryo-
cyte fate among cells expressing ICN4. Of note, bone marrow
cellularity and platelet counts in ICN4 animals were similar toStem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier Inc. 321
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(A) Rag1/ bone marrow cells were infected with ICN4-encoding or MIG control retroviruses and injected into wild-type lethally irradiated C57BL/6 recipients.
The MEP population was analyzed by flow cytometry. Representative analysis of myeloid progenitor populations in ICN4 recipients compared to controls (GFP+
or GFP gated population is indicated on the left side).
(B) Absolute numbers of MEP are indicated as mean ± SEM of three independent analyses.
(C) Megakaryocyte colony-forming unit (CFU-MK) potential from total bone marrow. Mean ± SEM of quadruplicate experiments is represented.
(D) Consecutive bone marrow sections from ICN4 and MIG recipients were stained as in Figure 5D. Arrowheads indicate GFP+ megakaryocytes. Original
magnification in the upper left four panels is 3100 and in the upper right panel is 31000.
(E) The number of GFP+ megakaryocytes and bone marrow (BM) cells were assessed as in Figure 5E. Histograms represent mean ± SEM of three independent
animals in each group.
(F) Flow cytometric analysis of megakaryocyte ploidy gated on GFP+CD41+ cells. Median ploidy is indicated in the histograms (value for diploid state = 2).
(G) Flow-sorted MEPs from the bone marrow of wild-type C57BL/6 animals were retrovirally transduced with empty control (MIG), ICN1, or ICN4 retroviruses and
injected into lethally irradiated recipients with 2 3 105 helper bone marrow cells. Bone marrow cells from recipients were analyzed 12 days posttransplant and
analysis was gated on GFP+ cells.MIG control animals (Figure S8 and data not shown). Further-
more, ploidy analysis revealed increased median ploidy content
of ICN4-expressing megakaryocytes (Figure 7F). Finally, to
confirm the role of Notch signaling on MEP in a Rag wild-type
context, we performed bone marrow transplantation with flow-
sorted MEPs from wild-type animals transduced with ICN4.
Analysis 12 days after transplant showed that ICN4 expression
in MEP resulted in increased megakaryocyte differentiation
and reduced erythroid differentiation in vivo (Figure 7G). Taken322 Cell Stem Cell 3, 314–326, September 11, 2008 ª2008 Elseviertogether, these data indicate that Notch4 signaling favors
MEP at the expense of GMP development and subsequently
potentiates megakaryopoiesis in vivo.
DISCUSSION
In toto, the present study shows that Notch signaling influences
megakaryocytic fate at several stages of primary hematopoietic
stem and progenitor cell differentiation both in vitro and in vivoInc.
Cell Stem Cell
Notch Specifies Megakaryocyte Fate(Figure S10). First, thesefindings support a role for Notch signaling
in the development of common MEPs from LSK cells and the con-
comitant inhibition of GMPs. The latter observation is in accord
with previous reports showing an inhibitory effect of Notch signal-
ing on granulocyte-macrophage differentiation (de Pooter et al.,
2006; Stier et al., 2002). Our results suggest that Notch-induced
megakaryocyte specification is mediated by both induction of
a megakaryocytic transcriptional program and selective induction
of apoptosis in the GMP compartment, reminiscent of the role of
Notch during T versus B lymphocyte differentiation. Of interest,
Notch-induced megakaryopoiesis was significantly more efficient
from LT- and ST-HSCs than from LMPPs, suggesting that al-
though canonical Notch signaling is dispensable for HSC mainte-
nance (Maillardetal., 2008), it playsa role in theirdifferentiation. As
reported recently, the Flt3+MPL+LSK population, a subfraction of
the LMPP compartment, may be responsible for the residual
erythromegakaryocytic potential of the LMPP (Luc et al., 2008).
Together, these results support an early commitment to the eryth-
romegakaryocytic lineage that branches from LT/ST-HSC prior to
lymphoid commitment (Adolfsson et al., 2005; Forsberg et al.,
2006; Luc et al., 2008; Pronk et al., 2007). In addition, these data
suggest that Notch signaling subsequently plays an important
role in the differentiation of megakaryocytic versus erythrocytic
cells. Indeed, although we observed an increase in the CFU-E
potential after short exposure of LSK cells to Notch ligand
in vitro, consistent with previous observations (Dando et al.,
2005) and with an increased differentiation toward MEP, further
development of the erythroid lineage was inhibited by Notch path-
way activation in vitro and in vivo, as previously shown in vitro in
the context of the erythromegakaryocytic K562 cell line (Ishiko
et al., 2005; Lam et al., 2000).
Global expression profiling of LSK cells grown on OP9-DL1
stromal cells using GSEA analysis suggests coordinate regula-
tion of Notch signaling with engagement of transcriptional pro-
grams that favor megakaryocytic development. Hes factors are
upregulated by DL1 stimulation and recapitulate, at least par-
tially, the effect of Notch pathway stimulation on megakaryocyte
development when expressed in LSK cells. Nevertheless, it is
likely that other direct or indirect targets of the Notch signaling
pathway are required to achieve maximal megakaryocyte devel-
opment. Of note, we observed an increased expression of the
transcription factors GATA-1, GATA-2, and FOG1/ZFPM1 that
are required for normal megakaryocyte development (Chang
et al., 2002; Shivdasani et al., 1997; Tsang et al., 1997) following
Notch stimulation of LSK cells. These observations are in conso-
nance with reports of Notch signaling promoting transcription
of the GATA factor Serpent (Mandal et al., 2004) in Drosophila
and expression of GATA-3 factor during T cell development
in mammals (Amsen et al., 2007; Fang et al., 2007) through
an RBPJk-dependent mechanism. Other reports indicate that
Notch directly controls GATA-2 expression in early hematopoi-
etic progenitors (de Pooter et al., 2006; Kumano et al., 2001).
By analogy, Notch signaling may play a similar role in megakar-
yocyte development by regulating expression and function of
GATA-1, GATA-2, or FOG1. In addition, our findings indicate
that Notch stimulation also results in upregulation of cytokine
receptors as well as structural proteins important for megakaryo-
cyte development. Of further interest, Notch has been reported
to induce transition from mitotic cell cycle to endocycle in Dro-Cellsophila follicle cells (Deng et al., 2001), suggesting that Notch
might also be involved in initiation of polyploidization, a hallmark
of megakaryocyte differentiation. Together, these data suggest
that Notch signaling may be a master regulator of several genes
critical for early megakaryocyte commitment from hematopoi-
etic stem and progenitor cells.
The mammalian Notch signaling pathway is complex, cell con-
text dependent, and involves multiple ligands and receptors
(Bray, 2006; Nam et al., 2007). Genetic pleiotropy among the
Notch ligands and receptors in mammals may be necessary for
regulation of cell-fate decisions at multiple branch points in
hematopoietic development (Radtke et al., 2004a). Our findings
are consistent with a positive role of DL1, Notch1, and Notch4
during megakaryocyte fate determination. Of note, ICN4 expres-
sion in LSK cells resulted primarily in the development of CD41+
cells, whereas ICN1 also promoted significant development of
Ter119+CD41+ cells in vitro. In addition, Notch1 showed the low-
est expression in MEP, whereas Notch4 showed the highest ex-
pression in this progenitor population, suggesting a physiological
role for Notch4 in megakaryocyte differentiation. Finally, only
ICN4 expression in MEP resulted in increased megakaryocyte
differentiation in vivo. These results suggest a potential stage-
specific role for Notch receptors during erythromegakaryocyte
and subsequent erythroid or megakaryocyte lineage commit-
ment. A role for Jagged ligands in megakaryopoiesis in vivo
seems less likely, given that culture of LSK cells on parental
OP9 stroma, known to express both Jagged1 and Jagged2
(Schmitt and Zuniga-Pflucker, 2002), does not result in significant
megakaryocyte development. However, further studies are
needed to characterize the Notch receptors, ligands, and cellular
targets that regulate megakaryocyte development in vivo. Of in-
terest, our data indicate that Notch stimulation potentiates
TPO-induced megakaryopoiesis of several hematopoietic pro-
genitors in vitro. Therefore, assessment of the interactions and
potential cooperative effects with cytokines signaling (i.e., the
TPO/MPL axis) during megakaryopoiesis will also be important.
Finally, these findings may have important clinical and thera-
peutic implications. For instance, they suggest the possibility
that Notch pathway blockade may be of potential value in hema-
tological malignancies associated with megakaryocytic hyper-
plasia, including essential thrombocythemia, polycythemia
vera, myeloid metaplasia with myelofibrosis, or acute megakar-
yoblastic leukemia (AMKL). The importance of Notch signaling in
the latter is supported by our recent findings that the OTT-MAL
(also known as RBM15-MKL1) fusion protein, exclusively associ-
ated with this type of AMKL, interacts with RBPJ through its OTT
moiety and alters its transcriptional properties (T.M., M.G.C., and
D.G.G., unpublished data). In addition, our results suggest that
Notch pathway stimulation may be of value in enhancing mega-
karyocyte growth and platelet production in clinical contexts as-
sociated with severe thrombocytopenia, such as hematopoietic
reconstitution following bone marrow transplantation or chemo-
therapy.
EXPERIMENTAL PROCEDURES
Coculture of Sorted Progenitors and Stromal Cells
OP9-GFP and OP9-DL1 stromal cells (a kind gift of Dr. Carlos Zu´n˜iga-Pflu¨cker)
were cultured in ‘‘OP9-media’’: a-MEM (StemCell Technologies) containingStem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier Inc. 323
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Notch Specifies Megakaryocyte Fate20% FCS (GIBCO), 50 mM 2-mercapto-ethanol (Chemicon), 2 mM glutamine
(GIBCO), 0.2% sodium bicarbonate (GIBCO), 100 U/ml penicillin, and 0.1
mg/ml streptomycin (GIBCO). The OP9 cells were plated on day 0 in 24-well
plates at a density of 23 104 cells/well. On day 1, 53 102–23 104 sorted pro-
genitors were plated onto the stroma in OP9 media, and half of the media was
changed every 3 days. g-secretase activity was inhibited with Compound E
(g-secretase inhibitor XXI, Calbiochem) or DAPT (g-secretase inhibitor IX, Cal-
biochem) at a final concentration of 1 mM. DMSO was used as vehicle-only
control. TPO (Peprotech) was used at the indicated concentrations. For anal-
ysis, hematopoietic cells were harvested from the supernatant of the cultures
and filtered through a 100 mm strainer. For microarray analysis, cells harvested
from the coculture were incubated for 1 hr in OP9 media on tissue-culture
treated plates, and only supernatants were collected to remove any residual
stromal cells before RNA extraction.
Flow Cytometric Analysis and Cell Sorting
All antibodies were obtained from BD PharMingen except anti-CD42b and
anti-CD41/CD61 (clone Xia.G5 and clone Leo.D2, respectively, Emfret), and
staining procedures were performed in PBS/2% FBS. For purification of LSK
by flow cytometry, murine bone marrow cells were first magnetically depleted
of lineage-positive cells with a cocktail of rat anti-mouse antibodies against all
mature blood cells, including Ter119, B220, CD3, CD4, CD8, IL7-R, CD19, and
Gr1. Residual lineage-positive cells were detected using a goat-anti-rat
PE-Cy5.5-conjugated antibody. To obtain LSK cells, cells were subsequently
stained with anti-CD34, c-kit, Sca-1 (BD PharMingen), and Fcg-RII/III (Abcam)
antibodies and sorted using a FACSAria (BD Biosciences). Human CD34+
bone marrow cells were obtained from AllCells. For in vitro cocultures of
LSK cells with stroma, analyses were gated on forward/side scatter profile
and CD45+ or CD45+GFP+ cells. Apoptosis assays were performed following
the manufacturer’s recommendations (AnnexinV-FITC Apoptosis Detection
Kit I, BD PharMingen). For ploidy analysis of LSK cells cocultured on OP9-
GFP or OP9-DL1 stroma at day 8, cells in the supernatant were stained with
anti-CD41-FITC and anti-CD45-APC antibodies. For ploidy analysis of bone
marrow transplant recipients, bone marrow cells were cultured in RPMI1640 +
10% FBS + 10 ng/ml of TPO for 4 days prior to fixation with 1% PFA and
staining with a primary rat anti-mouse CD41 and a secondary APC-conjugated
anti-rat antibody. In both cases, cells were subsequently incubated with 0.1%
sodium citrate solution containing 50 mg/ml RNase and 50 mg/ml propidium
iodide. Analysis was gated on CD41+CD45+ and CD41+GFP+ cells, respectively.
Data were analyzed using FlowJo or CellQuest (BD Biosciences) software.
Staining and Immunohistochemistry
Cytospins of hematopoietic cells from cocultures were prepared on glass
slides (Cytospin4, ThermoShandon). Slides were stained using Wright-Giemsa
Solutions (Sigma Diagnostics) or AchE staining solution (Stem Cell Technolo-
gies) following manufacturer’s recommendation. vWF (Dakocytomation) and
green fluorescent protein (GFP, Clone JL-8; Clontech, Palo Alto, CA) anti-
bodies were used to perform immunohistochemistry on paraffin-embedded
tissue sections at the Dana Farber/Harvard Cancer Center Specialized Histo-
pathology Services Core facility. CFU-MK potential was assessed using
MegaCult-C following the manufacturer’s recommendations (StemCell Tech-
nologies). Images were obtained using a Nikon Eclipse E400 microscope
with a 103/22 NA ocular lens (Nikon, Tokyo, Japan) and a SPOT RT color dig-
ital camera (model 2.1.1; Diagnostic Instruments). Low-power images (magni-
fication 3100) were obtained with a 103/0.25 objective lens, intermediate
power images (magnification 3400 and 3600) with a 403/1.3 NA and 603/
1.4 objective lenses with oil, and high-power images (31000) with a 1003/
1.4 objective lens with oil (Trak 300; Richard Allan Scientific). Images were an-
alyzed using Adobe Photoshop 6.0 (Adobe Systems).
RNA Extraction, Real-Time RT-PCR, and Microarray Analyses
RNA from LSK cells cocultured with OP9-GFP or OP9-DL1 cells for 5 days
was isolated using the RNeasy Mini Kit (QIAGEN). Expression levels of
Gata-1 (Mm00484678_m1 assay, Applied Biosystems), PU.1/SFPI-1
(Mm00488140_m1 assay, Applied Biosystems), Hes-1 (Mm00468601_m1
assay, Applied Biosystems), Hes-5 (Mm00439311_g1, Applied Biosystems),
Hey-1 (Mm00468865_m1, Applied Biosystems), Nrarp (Mm00482529_s1, Ap-
plied Biosystems), Fli-1 (Mm00484410_m1 assay, Applied Biosystems),324 Cell Stem Cell 3, 314–326, September 11, 2008 ª2008 Elsevier INotch1 (Mm00435245_m1, Applied Biosystems), Notch2 (Mm00803077_m1,
Applied Biosystems), Notch3 (Mm00435270_m1, Applied Biosystems), and
Notch4 (Mm00440525_m1, Applied Biosystems) were assessed by quantita-
tive RT-PCR (EZ RT-PCR Core Reagents, Applied Biosystems) following the
manufacturer’s recommendations and normalized to GAPDH (assay number
4352932E, Applied Biosystems).
For microarray analysis, RNA from LSK cells cultured 3 days on OP9-GFP,
OP9-DL1, or OP9-DL1 supplemented with Compound E was extracted using
the RNEasy Micro Kit (QIAGEN) following the manufacturer’s recommenda-
tions. For each condition, 25 ng of RNA was amplified and biotin labeled using
the Ovation Biotin system (Nugen) following the manufacturer’s recommenda-
tions. The labeled probes were then hybridized to Affymetrix (San Jose, CA)
Mouse Genome 430.2 (MOE430_2) GeneChip Arrays (45101 probe sets).
The ‘‘.CEL’’ files from the MAS5 software were used as starting points for all
analyses (three replicates per condition). Data were analyzed by using the R
statistical package bioconductor and data quality assessed by using functions
in the Affy and AffyPLM packages. The GCRMA algorithm (2.4.1) was used to
obtain normalized expression estimates. Genes that were selected for further
analysis had probe sets for which the expression value was greater than
27(log2) (which in our study constitutes the average background reading for
all probe sets) and a present flag call in at least two of three samples. To detect
significant changes in the expression levels, two-sample Welch t tests (para-
metric; assuming unequal variances; Benjamini and Hochberg step-up multi-
ple testing correction at a false discovery rate < 0.05) were applied to the re-
sulting genes. The resulting mouse genes associated with Mouse Genome
430 2.0 GeneChip arrays were extracted via the NetAffx Gene Ontology Mining
tool (Affymetrix). The ‘‘Notch Gene List’’ and the ‘‘Megakaryocyte Gene List’’
were generated based on the available literature reporting these genes as in-
volved in the Notch signaling pathway or upregulated during megakaryocyte
differentiation, respectively. These gene lists were subsequently used in all
GSEAs (Subramanian et al., 2005). The leading edge subset of genes was
determined by the GSEA criteria ‘‘core enrichment.’’ The data discussed in
this publication have been deposited in NCBI’s Gene Expression Omnibus
and are accessible through GEO Series accession number GSE11723.
Viral Infection, BoneMarrow Transplantation, and Poly(I:C) Injection
MSCV-DN-MAML1-GFP (kind gift from Dr. James D. Griffin), MSCV-IRES-
GFP (MIG)-ICN1, MIG-Hes1, MIG-Hes5 (kind gifts from Dr. Catherine Lavau)
(Kawamata et al., 2002), and MIG-ICN4 constructs are described elsewhere.
Viral supernatants were obtained as described previously (Mercher et al.,
2006). Similar viral titers were used for each retroviral construct, and transduc-
tion efficiencies in primary cells were confirmed for the various constructs by
flow cytometric analysis of GFP content. For transduction, 2 3 104 sorted
LSK cells were directly spin infected for 60 min at 2000 rpm with viral superna-
tant in IMDM containing 20% FBS, 20 ng/mL mIL6 (R&D systems), 10 ng/mL
mSCF (Peprotech, Rocky Hill, NJ), 10 ng/mL mIL11 (Peprotech, Rocky Hill,
NJ), 5 mg/mL Polybrene (American Bioanalytical), and 7.5 mM HEPES buffer
(GIBCO). Cells were incubated overnight in the same media and washed
and plated in OP9 media on stroma for 5–10 days before flow cytometric anal-
ysis. For bone marrow transplantation, Rag1/ (Jackson Laboratories) or
wild-type (Taconic) 8- to 10-week-old C57BL/6 donor mice were injected
with 5-FU (Sigma) 5 days prior to bone marrow collection from femurs and tib-
iae. After an overnight incubation in RPMI1640 supplemented with 10% FBS,
10 ng/mL mIL-3, 20 ng/mL mIL-6, and 10 ng/mL mSCF, cells were spin
infected with viral supernatants two times on day 1 and 2, and 1 3 106 were
injected into the tail vein of lethally irradiated wild-type C57BL/6 recipient
mice. Animals were analyzed 5–8 weeks after transplantation. For transplanta-
tion with MEP, MEP were flow sorted and directly infected once with MIG,
ICN1, or ICN4 retroviruses, and 5 3 104 MEPs were injected into the tail vein
of lethally irradiated wild-type C57BL/6 recipients along with 2 3 105 helper
whole bone marrow cells. Animals were analyzed 12 days after injection.
DnMAML1-GFP conditional knockin mice (Tu et al., 2005) were crossed with
Mx1-Cre (Jackson Laboratories). Double transgenic animals were induced
at 6 weeks of age with six to eight intraperitoneal injections of poly(I:C) (Sigma,
500 mg per injection) and analyzed 2–3 weeks later. Poly(I:C) injections lead to
excision of the Stop cassette in front of the dnMAML1-GFP allele and expres-
sion of the dnMAML1-GFP fusion, which can be tracked by flow cytometry
for GFP. Mx1-Cre transgenic animals injected with poly(I:C) were used asnc.
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Notch Specifies Megakaryocyte Fatewild-type controls. Approval for the use of animals in this study was granted by
the Children’s Hospital Boston Institutional Animal Care and Use Committee
(IACUC).
Statistical Analysis
Statistical significance of differences between the different conditions was
assessed using a two-tailed unpaired t test.
SUPPLEMENTAL DATA
The Supplemental Data include ten figures and two tables and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/3/3/
314/DC1/.
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